W E B I N A R : A Baby-Stepwise Approach to AUC Dosing in Pediatrics:Register now →

News & Media

DoseMe Enables Precision Dosing at Independence Health System

In this article:

Up to 30 Percent Time Savings for Patient Consults with Vital Accuracy and Efficiency Now Achieved in Dosing

Jupiter, FL – May 2, 2024

DoseMe, a leading provider of model-informed precision dosing (MIPD) software, has announced its collaboration with Excela Health, now part of Independence Health System. This alliance will advance therapeutic drug monitoring and optimize pharmacogenetics integration into pharmacokinetic/pharmacodynamic (PK/PD) models as part of IHS’s precision dosing strategy and initiatives.  
 
“DoseMe’s user friendly software is our preferred method of dosing as it takes away guess work and laborious time searching for updated records, freeing up our pharmacists to focus on what they do best,” said Robert Letterio, Pharmacy Supervisor at Independence. “The predictability is amazing and time savings for clinicians is anywhere from 25 – 30% per patient. We will continue to integrate new capabilities including AUC protocols with the incredible support of the DoseMe staff and extensive resource library.” 
 
Independence Health System offers patients nationally recognized quality care in cardiology, orthopedics, palliative care, and maternity as well as a broad range of surgical, medical, emergency, and behavioral health services, and an extensive network of primary care physicians. With five hospitals, nearly 1,000 healthcare providers and more than 7,000 employees, Independence Health System serves a ten county region and is the largest employer in Butler and Westmoreland counties. 
 
Dr. Sharmeen Roy, PharmD, BCPS, Chief Strategy and Science Officer, remarks on the partnership: “IHS’s commitment to excellence aligns perfectly with DoseMe’s vision. Our joint effort in precision dosing is set to decrease adverse drug events and cut healthcare costs significantly – key objectives in our shared agenda to enhance patient outcomes.”  
 
Looking forward, DoseMe’s innovative solutions will be fundamental for modern medicine, offering unprecedented accuracy in medication management. For more information on precision dosing models offered by  DoseMe, visit https://doseme-rx.com/why-dosemerx/drug-packages 

About DoseMe 

DoseMe combines smart technology with science, leveraging clinically validated PK/PD models, patient characteristics, drug concentrations, and genotype to accurately individualize a dose in seconds. The platform is HIPAA, ISO & FDA compliant and the only Bayesian dosing platform to be HITRUST CSF certified. For more information on successful applications of its products, DoseMeRx and DoseMe Analytics, visit https://doseme-rx.com/success-stories

HIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2024 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.